Grateful Grove LLC Stipulation Agreement Order
Summary
The Federal Trade Commission (FTC) issued a Stipulation Agreement Order against Grateful Grove LLC for deceptive advertising practices related to its "Get Sleep" product. The order prohibits the company from making unsubstantiated claims about the product's efficacy and requires specific disclosures.
What changed
This document is a Stipulation Agreement Order between the Federal Trade Commission (FTC) and Grateful Grove LLC, resolving allegations of deceptive advertising concerning the "Get Sleep" product. The FTC alleged that Grateful Grove made unsubstantiated claims about the product's ability to promote sleep and reduce anxiety. The Order prohibits Grateful Grove and its affiliates from making future deceptive claims regarding any drug, device, or dietary supplement, and requires specific disclosures regarding scientific substantiation for any health-related claims.
This order imposes significant compliance obligations on Grateful Grove LLC. The company must cease all deceptive advertising and implement a compliance program to ensure future adherence to FTC regulations. Failure to comply with the terms of the order could result in substantial penalties, including fines and further enforcement actions by the FTC. The effective date of the order is January 28, 2026.
What to do next
- Review advertising and marketing materials for compliance with FTC standards.
- Ensure all health-related claims for products are substantiated by competent and reliable scientific evidence.
- Implement a compliance program to monitor and enforce advertising standards.
Penalties
Civil penalties may be imposed for violations of the order.
Source document (simplified)
Page 1 of 7
Page 2 of 7
Page 3 of 7
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Cannabis Regulation alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when CO MED Final Actions publishes new changes.